STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Check-Cap Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Check-Cap Ltd. (CHEK) rescheduled its Annual General Meeting to November 14, 2025 at 10:00 a.m. ET at Paul Hastings LLP in Washington, DC. Shareholders of record as of September 16, 2025 may vote. The proxy materials previously furnished are incorporated by reference, with an updated Reverse Split Proposal range of 1-for-2 to 1-for-100. The number of authorized ordinary shares will remain 18,000,000, and the nominal value will remain NIS 48.0 per share even if the reverse split is approved.

The company also provided an update on its proposed merger with MBody AI. Under the September 12, 2025 Merger Agreement, a Check-Cap subsidiary will merge into MBody AI, which will survive as a wholly owned subsidiary of Check-Cap. The Board affirmed that the originally disclosed exchange ratio is being preserved. Subject to satisfaction or waiver of closing conditions and shareholder approval, the parties expect to consummate the merger in the weeks following approval.

Positive
  • None.
Negative
  • None.

Insights

Administrative updates: AGM timing, reverse split parameters, and merger path.

The filing resets the AGM to November 14, 2025 with a record date of September 16, 2025. It refines the reverse split proposal to a range of 1-for-2 to 1-for-100 while explicitly keeping authorized ordinary shares at 18,000,000 and nominal value at NIS 48.0 per share.

On the transaction, Check-Cap and MBody AI remain on course under the September 12, 2025 Merger Agreement: a merger sub will combine with MBody AI, which will become a wholly owned subsidiary. The Board states the originally disclosed exchange ratio is preserved. Closing is expected in the weeks following shareholder approval, subject to closing conditions.

Key dependencies are shareholder approval and satisfaction or waiver of closing conditions. Subsequent filings may provide definitive closing timing and any post‑closing actions.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2025

 

Commission File Number: 001-36848

 

Check-Cap Ltd.

(Exact Name of Registrant as Specified in Charter)

 

Abba Hushi Avenue
P.O. Box 1271
Isfiya, 30090 Mount Carmel, Israel
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

This Form 6-K is being incorporated by reference into Check-Cap Ltd.’s Registration Statements on Form F-3 (File No. 333-262401) and Form S-8 (File Nos. 333-203384, 333-226490 and 333-259666) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Annual General Meeting of Shareholders – Rescheduling Notice

 

Check-Cap Ltd. (the “Company”, or “Check-Cap”) has determined to reschedule its Annual General Meeting of Shareholders (“AGM”) originally scheduled for October 17, 2025. The AGM will be held on Friday, November 14, 2025, at 10:00 a.m., Eastern Time, at Paul Hastings LLP, 2050 M St NW, Washington, DC 20036, United States. A copy of the Notice of the Annual General Meeting of Shareholders, the Proxy Statement as well as the Proxy Card are attached as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3, respectively, to the Form 6-K previously furnished with the U.S. Securities and Exchange Commission on September 12, 2025 and are incorporated herein by reference except that the proposed reverse split ratio in the Reverse Split Proposal (as defined below) will be within a range of 1 for 2 to 1 for 100, and the number of authorized ordinary shares will remain at 18,000,000 shares and the nominal value of the ordinary shares will remain at NIS 48.0 per share even if the Reverse Split Proposal is approved. All holders of record of the ordinary shares as of the close of business on September 16, 2025, the record date for the AGM, will be entitled to vote at the AGM. 

 

Update on Proposed Business Combination

 

On September 12, 2025, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MBody AI, a Nevada corporation (“MBody AI”), and CC Merger Sub Inc., a Nevada corporation and direct wholly owned subsidiary of Check-Cap (“Merger Sub”). Pursuant to the Merger Agreement, Merger Sub will merge with and into MBody AI, with MBody AI surviving as a wholly owned subsidiary of Check-Cap (such transaction, the “Merger”), forging a dynamic alliance set to generate enhanced shareholder value through market-leading advancements in embodied AI-driven automation.

 

1

 

 

MBody AI Business Update

 

Since the announcement, MBody AI’s pipeline and active deployments have surged dramatically, propelled by significant inbound demand from premier clients in hospitality, logistics, and healthcare determined to capitalize on embodied-AI capabilities. This robust momentum has ignited a series of landmark multi-year contracts and strategic expansion dialogues with esteemed global brands. MBody AI is advancing with remarkable velocity, achieving swift progress in growth, customer integration, and commercial dominance, firmly establishing itself as a market-leader in embodied artificial intelligence technologies. Central to this ascent is the MBody AI Orchestrator, MBody AI’s innovative “Brains of Autonomy” AI stack, which empowers advanced, responsive robotic and embedded systems, transforming efficiencies across hospitality, warehousing, healthcare, and office management sectors.

 

Institutional and strategic interest in MBody AI has escalated profoundly, attracting keen involvement from leading banks, prominent family offices, and elite global funds pursuing pre- and post-closing opportunities. Inbound investment inquiries have escalated to hundreds of millions of dollars, offering compelling third-party endorsement of MBody AI’s strengthened valuation and vigorous growth momentum. This outstanding performance and preeminent market stance have catalyzed a substantial elevation in MBody AI’s valuation, prompting both parties—after thorough deliberations with their boards, advisors, and investors—to optimize the transaction terms to encapsulate MBody AI’s amplified ambitions and bright prospects. In a significant advantage for shareholders, Check-Cap’s Board of Directors (the “Board”) is pleased to affirm that MBody AI is preserving the originally disclosed exchange ratio.

 

Check-Cap is deeply satisfied to have secured MBody AI as its merger partner at this opportune moment. This calculated alignment situates shareholders at the forefront of one of the most profound transformations in today’s capital markets—embodied AI—widely acclaimed by visionary investment companies like Goldman Sachs and Morgan Stanley as a ‘once-in-a-generation category-defining breakthrough.’ By moving with precision and resolve, Check-Cap has acquired a partner that could have otherwise accessed public markets via rival avenues, such as high-profile IPOs or SPACs. MBody AI’s decision to partner with Check-Cap illuminates the unparalleled access now afforded to our shareholders: immersion in a rapid-ascension, pre-institutional narrative typically exclusive to top venture capital or private equity circles. This partnership provides public-market participants with a distinguished share in a venture during its high-growth surge, reflecting a collective dedication to forging a distinguished, publicly listed frontrunner in the domain.

 

Check-Cap shareholders are ideally placed at the vanguard of a groundbreaking technological evolution. Embodied AI is spearheading what Morgan Stanley analysts characterize as a revolutionary wave akin to the internet, poised to generate trillions in AI-enabled economic impact.

 

Through this timely union with MBody AI, Check-Cap grants its shareholders premium access to an industry anticipated to escalate from billions in current value to trillions by 2030 for AI robotics alone, with embodied systems potentially contributing to a $16 trillion market opportunity by 2050.

 

2

 

 

Investor Cathie Wood emphasizes that AI robots represent "the biggest of all the embodied AI opportunities," amplifying the strategic significance of MBody AI’s selection of Check-Cap and positioning their shareholders for a commanding role in the AI advancement landscape often reserved for industry elites.

 

The Board is exceptionally proud to deliver this transaction to shareholders, representing the pinnacle of meticulous, multinational coordination by premier legal, audit, and investment banking experts. This refined architecture, developed under rigorous examination, exemplifies both entities’ capacity to execute pivotal corporate achievements with efficiency and precision.

 

Next Steps and Meeting Purpose

 

At the AGM, shareholders will be asked to consider and vote upon:

 

1.Approval of the Merger Agreement to effect the Merger and other transactions in connection with the Merger;

 

2.Approval of a reverse share split of the Company’s ordinary shares within a range of 1 for 2 to 1 for 100, the exact ratio to be determined by further action of the Board, to be effective on a date to be determined by the Board (the “Reverse Split Proposal”);

 

3.Election of all four directors as members of the Board, each to serve until the next annual general meeting of shareholders and until their respective successors are duly elected and qualified or their earlier resignation or removal; and

 

4.Approval of the change of Check-Cap’s name to “MBody AI Ltd.” or a similar name approved by the Israeli Registrar of Companies, effective as of the effective time under the Merger Agreement and to amend the Articles of Association of the Company to reflect the name change.

 

Subject to satisfaction or waiver of the closing conditions under the Merger Agreement, the parties expect to consummate the Merger in the weeks following shareholder approval. With the Merger approaching swift closure, the unified company is prepared to implement cross-listing and institutional alignment measures, elevating its standing among foremost global AI and robotics entities. Management firmly believes these actions will unlock considerable enhanced value for committed long-term shareholders.

 

The Future is Now

 

As the closing nears, Check-Cap shareholders should regard this as more than approving a merger—it is an invitation to stake a claim in the innovations of tomorrow. The emergent organization will emerge as a robust global AI authority, pursuing ambitious plans for additional cross-listing, index incorporation, and expansive international growth. Trailblazers in revolutionary technologies—from Amazon to Tesla to NVIDIA—have yielded remarkable returns. Today, Check-Cap shareholders possess that equivalent, compelling potential.

 

Forward-Looking Statements

 

This Report on Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the anticipated timing and completion of the Merger, expected benefits of the Merger, the combined company’s business strategy and prospects, and other matters. These statements are based on current expectations and are subject to various risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include, among others, the risk that the conditions to closing are not satisfied, changes in market conditions, regulatory approvals, integration challenges, and general economic factors. The Company undertakes no obligation to update these statements, except as required by law.

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CHECK-CAP LTD.
  (Registrant)
   
Date: November 4, 2025 By: /s/ David Lontini
  Name:  David Lontini
  Title: Chairman and Interim Chief Executive Officer

 

 

4

 

FAQ

When and where is Check-Cap’s (CHEK) rescheduled AGM?

The AGM is on November 14, 2025 at 10:00 a.m. ET at Paul Hastings LLP, 2050 M St NW, Washington, DC 20036.

Who can vote at Check-Cap’s 2025 AGM?

All holders of record of ordinary shares as of September 16, 2025 are entitled to vote.

What are the updated reverse split parameters for CHEK?

The Reverse Split Proposal specifies a range of 1-for-2 to 1-for-100.

Will authorized shares or nominal value change if the reverse split is approved?

Authorized ordinary shares will remain at 18,000,000 and nominal value will remain NIS 48.0 per share.

What is the structure of the MBody AI merger with Check-Cap?

A Check-Cap subsidiary will merge into MBody AI, and MBody AI will survive as a wholly owned subsidiary of Check-Cap.

What merger terms did Check-Cap reaffirm?

The Board affirmed that the originally disclosed exchange ratio will be preserved.

When could the MBody AI merger close?

Subject to shareholder approval and closing conditions, the parties expect to close in the weeks following approval.
Check Cap

NASDAQ:CHEK

CHEK Rankings

CHEK Latest News

CHEK Latest SEC Filings

CHEK Stock Data

9.89M
5.56M
20.82%
1.73%
0.46%
Diagnostics & Research
Healthcare
Link
Israel
Isfiya